Voyager Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -29.6% | -29.6% | -21.2% |
| FY2017 | -52.7% | -52.7% | -38.3% |
| FY2018 | -190.1% | -190.1% | -49.9% |
| FY2019 | -43.8% | -43.8% | -12.3% |
| FY2020 | 23.8% | 23.8% | 14.0% |
| FY2021 | -74.9% | -74.9% | -36.7% |
| FY2022 | -78.6% | -78.6% | -29.1% |
| FY2023 | 56.0% | 56.0% | 37.7% |
| FY2024 | -21.7% | -21.7% | -16.5% |
| FY2025 | -61.1% | -61.1% | -47.5% |